1.
Nurs Clin North Am
; 50(4): 679-90, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26596656
RESUMO
At present there is a lack of well-validated surveys used to measure quality of life in patients with malignant brain tumors and their caregivers. The main objective of this pilot study was to validate the National Institutes of Health Patient-Reported Outcomes Measurement Information System (NIH PROMIS) survey for use as a quality-of-life measure in this population. This article presents the rationale for using the NIH PROMIS instrument as a quality-of-life measure for patients with malignant brain tumors and their caregivers.